Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 32Pain, Postoperative 18Neoplasms 16Parkinson Disease 4, Autosomal Dominant Lewy Body 13Lung Neoplasms 12Brain Neoplasms 12Prostatic Neoplasms 9Ovarian Neoplasms 9Colonic Neoplasms 8Carcinoma, Hepatocellular 8Stomach Neoplasms 7Depression 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Pain 6Head and Neck Neoplasms 6Thyroid Neoplasms 5Pancreatic Neoplasms 5Multiple Myeloma 5Leiomyoma 5Agnosia 5Neoplasm Metastasis 4Lymphoma 4Fatigue 4Delirium 4Anxiety Disorders 4Urinary Bladder Neoplasms 3Thromboembolism 3Supratentorial Neoplasms 3Stomatitis 3

Interventions

Mifepristone 3Corlux 3Thyrotropin-Releasing Hormone 1Surgical Procedures, Operative 1Sodium Chloride 1Saline Solution 1Radiotherapy 1Radiomics 1Nivolumab 1Magnetic Resonance Spectroscopy 1LY2940680 1Ipilimumab 1Hydrocortisone 1Human Growth Hormone 1Diazoxide 1Dexmedetomidine 1Dexamethasone 1Biomarkers 1Anesthesia, Local 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pituitary Diseases × Saline Solution × Clear all
NCT02549768 2016-10-12

Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery

Pontificia Universidad Catolica de Chile

Phase 4 Unknown
40 enrolled
Endocrine

Pituitary Diseases, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡